Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications

Journal of Photochemistry and Photobiology B: Biology

Volumn 98, Issue 1, 2010, Pages 77-94

  Leblond, Frederic ^a   Davis, Scott C ^a   Valdés, Pablo A ^a   Pogue, Brian W ^a,b  

^a DARTMOUTH COLLEGE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Commercial; Diagnostic; Fluorescence; Imaging; Small animal; Tomography

Indexed keywords

FLUORESCENT DYE;

ARTICLE; AUTOFLUORESCENCE; BIOMEDICAL TECHNOLOGY ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ELECTROMAGNETIC FIELD; EQUIPMENT DESIGN; FLUORESCENCE ANALYSIS; FLUORESCENCE IMAGING; HUMAN; ILLUMINATION; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; IN VIVO STUDY; INSTRUMENTATION; LIGHT ABSORPTION; LIGHT SCATTERING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; ULTRASOUND; WHOLE BODY IMAGING;

ANIMALS; DRUG EVALUATION, PRECLINICAL; FLUORESCENCE; MAGNETIC RESONANCE IMAGING; MICE; TOMOGRAPHY; WHOLE BODY IMAGING; WHOLE-BODY IRRADIATION;

ANIMALIA;

EID: 73249116830     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2009.11.007     Document Type: Article

References (178)

1. Jacques S.L., and Pogue B.W. Tuturial on diffuse light transport. J. Biomed. Opt. 13 4 (2008) 041302
2. Swartling J., et al. Fluorescence spectra provide information on the depth of fluorescent lesions in tissue. Appl. Opt. 44 10 (2005) 1934-1941
3. Davis S.C., et al. Contrast-detail analysis characterizes diffuse optical fluorescence tomography image reconstruction. J. Biomed. Opt. 10 5 (2005) 050501-1-3
4. Billinton N., and Knight A.W. Seeing the wood through the trees: a review of techniques for distinguishing green fluorescent protein from endogenous autofluorescence. Anal. Biochem. 291 (2001) 175-197
5. Wagnieres G.A., Star W.M., and Wilson B.C. In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem. Photobiol. 68 5 (1998) 603-632
6. Mansfield J.R., et al. Autofluorescence removal, multiplexing, and automated analysis methods for in-vivo fluorescence imaging. J. Biomed. Opt. 10 4 (2005) 041207-1-9
7. Davis S.C., et al. Image guided diffuse optical fluorescence tomography implemented with Laplacian-type regularization. Opt. Express 15 7 (2007) 4066-4082
8. Hillman E.M.C., and Moore A. All-optical anatomical co-registration for molecular imaging of small animals using dynamic contrast. Nat. Photon. 1 (2007) 526-530
9. Richards-Kortum R., and Sevick-Muraca E. Quantitative optical spectroscopy for tissue diagnosis. Ann. Rev. Phys. Chem. 47 (1996) 555-606
10. Jacques S.L., and Pogue B.W. Tutorial on diffuse light transport. J. Biomed. Opt. 13 14 (2008) 041302
11. Pogue B.W., Gibbs S.L., and Chen B. Fluorescence imaging in vivo: raster scanned point-source imaging provides more accurate quantification than broad beam geometries. Tech. Cancer Res. Treat. 3 1 (2004) 15-21
12. Pogue B.W., and Burke G.C. Fiber optic bundle design for quantitative fluorescence measurement from tissue. Appl. Opt. 37 31 (1998) 7429-7436
13. Soubret A., Ripoll J., and Ntziachristos V. Accuracy of fluorescent tomography in the presence of heterogeneities: study of the normalized born ratio. IEEE Trans. Med. Imag. 24 10 (2005) 1377-1386
14. Sinaasappel M., and Sterenborg H.J.C.M. Quantification of the hematoporphyrin derivative by fluorescence measurement using dual-wavelength excitation and dual-wavelength detection. Appl. Opt. 32 4 (1993) 541-548
15. Hillman E.M., and Moore A. All-optical anatomical co-registration for molecular imaging of small animals using dynamic contrast. Nat. Photon. 1 9 (2007) 526-530
16. Takeda M., and Mutoh K. Fourier transform profilometry for the automatic measurement of 3-D object shapes. Appl. Opt. 22 24 (1983) 3977-3982
17. Ntziachristos V., et al. Fluorescence molecular tomography resolves protease activity in vivo. Nat. Med. 8 7 (2002) 757-760
18. McCann C.M., et al. Combined magnetic resonance and fluorescence imaging of the living mouse brain reveals glioma response to chemotherapy. Neuroimage 45 2 (2009) 360-369
19. Gibbs-Strauss S.L., et al. Noninvasive measurement of aminolevulinic acid-induced protoporphyrin IX fluorescence allowing detection of murine glioma in vivo. J. Biomed. Opt. 14 1 (2009) 014007-1-8
20. Veiseh M., et al. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res. 67 14 (2007) 6882-6888
21. Hyde D., et al. Hybrid FMT-CT imaging of amyloid-beta plaques in a murine Alzheimer's disease model. Neuroimage 44 4 (2009) 1304-1311
22. Hintersteiner M., et al. In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe. Nat. Biotechnol. 23 5 (2005) 577-583
23. Wang Q., et al. Visualizing localized dynamic changes during epileptic seizure onset in vivo with diffuse optical tomography. Med. Phys. 35 1 (2008) 216-224
24. Klohs J., et al. Near-infrared fluorescence imaging with fluorescently labeled albumin: a novel method for non-invasive optical imaging of blood-brain barrier impairment after focal cerebral ischemia in mice. J. Neurosci. Methods. 180 1 (2009) 126-132
25. Klohs J., et al. In vivo imaging of the inflammatory receptor CD40 after cerebral ischemia using a fluorescent antibody. Stroke 39 10 (2008) 2845-2852
26. Klohs J., et al. In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia. J. Cereb. Blood Flow Metab. (2009)
27. Johnson N.D., Duysen E.G., and Lockridge O. Intrathecal delivery of fluorescent labeled butyrylcholinesterase to the brains of butyrylcholinesterase knock-out mice: visualization and quantification of enzyme distribution in the brain. Neurotoxicology 30 3 (2009) 386-392
28. Pham W., et al. Crossing the blood-brain barrier: a potential application of myristoylated polyarginine for in vivo neuroimaging. Neuroimage 28 1 (2005) 287-292
29. Deguchi J.O., et al. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 114 1 (2006) 55-62
30. Chen J., et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation 105 23 (2002) 2766-2771
31. Nahrendorf M., et al. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 117 3 (2008) 379-387
32. Sosnovik D.E., et al. Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation 115 11 (2007) 1384-1391
33. Shepherd J., et al. A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages. Chem. Biol. 14 11 (2007) 1221-1231
34. Sosnovik D.E., et al. Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation 115 (2007) 1384-1391
35. Nahrendorf M., et al. Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct. Circ. Res. 100 8 (2007) 1218-1225
36. Urano Y., et al. Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes. Nat. Med. 15 1 (2009) 104-109
37. Haller J., et al. Visualization of pulmonary inflammation using noninvasive fluorescence molecular imaging. J. Appl. Physiol. 104 (2008) 795-802
38. Grimm J., et al. Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. Proc. Natl. Acad. Sci. USA 102 40 (2005) 14404-14409
39. Koenig A., et al. In vivo mice lung tumor follow-up with fluorescence diffuse optical tomography. J. Biomed. Opt. 13 1 (2008) 011008 1-9
40. Grimm J., et al. Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. PNAS 102 40 (2005) 14404-14409
41. Cortez-Retamozo V., et al. Real-time assessment of inflammation and treatment response in a mouse model of allergic airway inflammation. J. Clin. Invest. 118 12 (2008) 4058-4066
42. Montet X., et al. Tomographic fluorescence imaging of tumor vascular volume in mice. Radiology 242 3 (2007) 751-758
43. von Burstin J., et al. Highly sensitive detection of early-stage pancreatic cancer by multimodal near-infrared molecular imaging in living mice. Int. J. Cancer. 123 9 (2008) 2138-2147
44. Snyder C.S., et al. Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer. BMC Cancer 9 (2009) 106
45. Wack S., et al. Feasibility, sensitivity, and reliability of laser-induced fluorescence imaging of green fluorescent protein-expressing tumors in vivo. Mol. Ther. 7 6 (2003) 765-773
46. K. Samkoe et al., A study of MRI-guided fluorescence molecular tomography for monitoring PDT effects in pancreas cancer, SPIE Proceedings: IPA - PDT Dosimetry, 7380, paper 73803M, 2009.
47. Kobayashi H., et al. Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging. ACS Nano. 1 4 (2007) 258-264
48. Hama Y., et al. Two-color lymphatic mapping using Ig-conjugated near infrared optical probes. J. Invest. Dermatol. 127 10 (2007) 2351-2356
49. Hama Y., et al. Spectral near-infrared fluorescence imaging of curved surfaces using projection reconstruction algorithms. Contrast Media Mol. Imag. 2 2 (2007) 82-87
50. Talanov V.S., et al. Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging. Nano. Lett. 6 7 (2006) 1459-1463
51. Garofalakis A., et al. Three-dimensional in vivo imaging of green fluorescent protein-expressing T cells in mice with noncontact fluorescence molecular tomography. Mol. Imag. 6 2 (2007) 96-107
52. Martin A., et al. Imaging changes in lymphoid organs in vivo after brain ischemia with three-dimensional fluorescence molecular tomography in transgenic mice expressing green fluorescent protein in T lymphocytes. Mol. Imag. 7 4 (2008) 157-167
53. Swirski F.K., et al. A near-infrared cell tracker reagent for multiscopic in vivo imaging and quantification of leukocyte immune responses. PLoS ONE 2 10 (2007) e1075
54. Christen T., et al. Molecular imaging of innate immune cell function in transplant rejection. Circulation 119 14 (2009) 1925-1932
55. Kozloff K.M., Weissleder R., and Mahmood U. Noninvasive optical detection of bone mineral. J. Bone Miner. Res. 22 8 (2007) 1208-1216
56. Zaheer A., et al. In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat. Biotechnol. 19 12 (2001) 1148-1154
57. Aikawa E., et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 116 24 (2007) 2841-2850
58. Zilberman Y., et al. Fluorescence molecular tomography enables in vivo visualization and quantification of nonunion fracture repair induced by genetically engineered mesenchymal stem cells. J. Orthop. Res. 26 4 (2008) 522-530
59. Kozloff K.M., et al. Non-invasive optical detection of cathepsin K-mediated fluorescence reveals osteoclast activity in vitro and in vivo. Bone 44 2 (2009) 190-198
60. Mitsiades C.S., et al. Fluorescence imaging of multiple myeloma cells in a clinically relevant SCID/NOD in vivo model: biologic and clinical implications. Cancer Res. 63 20 (2003) 6689-6896
61. Cross N.A., et al. Imaging the effects of castration on bone turnover and hormone-independent prostate cancer colonization of bone. Prostate 68 15 (2008) 1707-1714
62. Fournier P.G., et al. Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo. Cancer Res. 68 21 (2008) 8945-8953
63. Wunder A., et al. In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheu. 50 8 (2004) 2459-2465
64. Chen W.T., et al. Arthritis imaging using a near-infrared fluorescence folate-targeted probe. Arthritis Res. Ther. 7 2 (2005) R310-R317
65. Izmailova E.S., et al. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis. Arthritis Rheum. 56 1 (2007) 117-128
66. Hama Y., et al. A self-quenched galactosamine-serum albumin-rhodamineX conjugate: a "smart" fluorescent molecular imaging probe synthesized with clinically applicable material for detecting peritoneal ovarian cancer metastases. Clin. Cancer Res. 13 21 (2007) 6335-6343
67. Hama Y., et al. Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidin. Biochem. Biophys. Res. Commun. 348 3 (2006) 807-813
68. Xu H., et al. Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Bioconjug. Chem. 18 5 (2007) 1474-1482
69. Gunn A.J., et al. Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore. Cancer Sci. 98 11 (2007) 1727-1733
70. Hama Y., et al. A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate. Cancer Res. 67 6 (2007) 2791-2799
71. Kamiya M., et al. An enzymatically activated fluorescence probe for targeted tumor imaging. J. Am. Chem. Soc. 129 13 (2007) 3918-3929
72. Hama Y., et al. D-galactose receptor-targeted in vivo spectral fluorescence imaging of peritoneal metastasis using galactosamin-conjugated serum albumin-rhodamine green. J. Biomed. Opt. 12 5 (2007) 051501
73. Chang S.K., et al. In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment. Clin. Cancer. Res. 14 13 (2008) 4146-4153
74. Bogdanov Jr. A.A., Lin C.P., and Kang H.W. Optical imaging of the adoptive transfer of human endothelial cells in mice using anti-human CD31 monoclonal antibody. Pharm. Res. 24 6 (2007) 1186-1192
75. Cai W., et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano. Lett. 6 4 (2006) 669-676
76. Mayes P., et al. Noninvasive vascular imaging in fluorescent tumors using multispectral unmixing. Biotechniques 45 4 (2008) 459-460 p. 461-464
77. Hama Y., et al. Two-color in vivo dynamic contrast-enhanced pharmacokinetic imaging. J. Biomed. Opt. 12 3 (2007) 034016
78. Caceres G., et al. Imaging of luciferase and GFP-transfected human tumours in nude mice. Luminescence 18 4 (2003) 218-223
79. Diehn F.E., et al. Noninvasive fluorescent imaging reliably estimates biomass in vivo. Biotechniques 33 6 (2002) 1250-1252 p. 1254-1255
80. Choy G., et al. Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging. Biotechniques 35 5 (2003) 1022-1026 p. 1028-1030
81. Yang M., et al. Visualizing gene expression by whole-body fluorescence imaging. Proc. Natl. Acad. Sci. USA 97 22 (2000) 12278-12282
82. Vera D.R., et al. Cy5.5-DTPA-galactosyl-dextran: a fluorescent probe for in vivo measurement of receptor biochemistry. Nucl. Med. Biol. 32 7 (2005) 687-693
83. Su J., et al. Exploring feasibility of multicolored CdTe quantum dots for in vitro and in vivo fluorescent imaging. J. Nanosci. Nanotechnol. 8 3 (2008) 1174-1177
84. Zhang J., et al. Evaluation of red CdTe and near infrared CdHgTe quantum dots by fluorescent imaging. J. Nanosci. Nanotechnol. 8 3 (2008) 1155-1159
85. Gao X., et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22 8 (2004) 969-976
86. Bullok K.E., et al. Biochemical and in vivo characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. Biochemistry 46 13 (2007) 4055-4065
87. von Wallbrunn A., et al. In vivo optical imaging of CD13/APN-expression in tumor xenografts. J. Biomed. Opt. 13 1 (2008) 011077 1-011077 9
88. Koyama Y., et al. In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies. Neoplasia 9 12 (2007) 1021-1029
89. Barrett T., et al. In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies. Clin. Cancer Res. 13 22 Pt 1 (2007) 6639-6648
90. Gee M.S., et al. Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy. Radiology 248 3 (2008) 925-935
91. Bremer C., et al. Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. Radiology 221 2 (2001) 523-529
92. Daldrup-Link H.E., et al. Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy. Eur. J. Nucl. Med. Mol. Imag. 31 9 (2004) 1312-1321
93. Lisy M.R., et al. In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice. Radiology 247 3 (2008) 779-787
94. Duysen E.G., and Lockridge O. Whole body and tissue imaging of the butyrylcholinesterase knockout mouse injected with near infrared dye labeled butyrylcholinesterase. Chem. Biol. Interact. 175 1-3 (2008) 119-124
95. Zacharakis G., et al. Normalized transillumination of fluorescent proteins in small animals. Mol. Imag. 5 3 (2006) 153-159
96. Wall A., et al. Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG). Breast Cancer Res. 10 2 (2008) R23
97. Montet X., et al. Tomographic fluorescence mapping of tumor targets. Cancer Res. 65 14 (2005) 6330-6336
98. von Wallbrunn A., et al. In vivo imaging of integrin alphav-beta3 expression using fluorescence-mediated tomography. Eur. J. Nucl. Med. Mol. Imag. 34 (2007) 745-754
99. Bremer C., Ntziachristos V., and Weissleder R. Optical-based molecular imaging: contrast agents and potential medical applications. Eur. Radiol. 13 2 (2003) 231-243
100. Weissleder R., and Mahmood U. Molecular imaging. Radiology 219 2 (2001) 316-333
101. Weissleder R. Molecular imaging: exploring the next frontier. Radiology 212 3 (1999) 609-614
102. Hoffman R.M. A better fluorescent protein for whole-body imaging. Trends Biotechnol. 26 1 (2008) 1-4
103. Schcherbo D., et al. Bright far-red fluorescent protein for whole-body imaging. Nat. Methods. 4 9 (2007) 741-746
104. Shkrob M.A., et al. Far-red flurorescent proteins evolved from a blue chromoprotein from Actinia equina. Biochem. J. 392 (2005) 649-654
105. Shu X., et al. Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science 324 804-807 (2009)
106. Hassan M., et al. Fluorescence lifetime imaging system for in vivo studies. Mol. Imag. 6 4 (2007) 229-236
107. Bloch S., et al. Whole-body fluorescence lifetime imaging of a tumor-targeted near-infrared molecular probe in mice. J. Biomed. Opt. 10 5 (2005) 054003
108. Hutchinson C.L., Lakowicz J.R., and Sevick-Muraca E.M. Fluorescence lifetime-based sensing in tissues: a computational study. Biophys. J. 68 4 (1995) 1574-1582
109. Kuwana E., and Sevick-Muraca E.M. Fluorescence lifetime spectroscopy in multiply scattering media with dyes exhibiting multiexponential decay kinetics. Biophys. J. 83 2 (2002) 1165-1176
110. Hattery D., et al. Analytical solutions for time-resolved fluorescence lifetime imaging in a turbid medium such as tissue. J. Opt. Soc. Am. A 18 7 (2001) 15231530
111. J. Gruber et al., System for fluorescence quantification of thin tissue layers guided by high frequency ultrasound. in: SPIE BiOS: Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy, vol. XVIII, SPIE Press, San Jose, 2009.
112. Zacharakis G., et al. Fluorescent protein tomography scanner for small animal imaging. IEEE Trans. Med. Imag. 24 7 (2005) 878-885
113. Deliolanis N., et al. Free-space fluorescence molecular tomography utilizing 360 degrees geometry projections. Opt. Lett. 32 4 (2007) 382-384
114. Ntziachristos V., and Weissleder R. Charge-coupled-device based scanner for tomography of fluorescent near-infrared probes in turbid media. Med. Phys. 29 5 (2002) 803-809
115. Patwardhan S.V., et al. Time-dependent whole-body fluorescence tomography of probe bio-distribution in mice. Opt. Express 13 7 (2005) 2564-2577
116. Graves E.E., et al. A submillimeter resolution fluorescence molecular imaging system for small animal imaging. Med. Phys. 30 5 (2003) 901-911
117. Davis S.C., et al. Magnetic resonance-coupled fluorescence tomography scanner for molecular imaging of tissue. Rev. Sci. Instr. 79 (2008) 064302-1-064302-10
118. Zavattini G., et al. A hyperspectral fluorescence system for 3D in vivo optical imaging. Phys. Med. Biol. 51 (2006) 2029-2043
119. Leavesley S., et al. An excitation wavelength-scanning spectral imaging system for preclinical imaging. Rev. Sci. Instrum. 79 (2008) 023707-1-023707-10
120. Li C., et al. A three-dimensional multispectral fluorescence optical tomography imaging system for small animals based on a conical mirror design. Opt. Express 17 9 (2009) 7571-7585
121. Kepshire D.S., et al. A microcomputed tomography guided fluorescence tomography system for small animal molecular imaging. Rev. Sci. Instrum. 80 (2009) 043701
122. Brambilla M., et al. Time-resolved scanning system for double reflectance and transmittance fluorescence imaging of diffusive media. Rev. Sci. Instrum. 79 (2008) 013103 1-013103 9
123. Kumar A.T.N., et al. A time domain fluorescence tomography system for small animal imaging. IEEE Trans. Med. Imag. 27 8 (2008) 1152-1163
124. Niedre M.J., et al. Early photon tomography allows fluorescence detection of lung carcinomas and disease progression in mice in vivo. PNAS 105 49 (2008) 19126-19131
125. Lam S., Lesage F., and Intes X. Time domain fluorescent diffuse optical tomography: analytical expressions. Opt. Express 13 (2005) 2263-2275
126. Riley J., et al. Choice of data types in time resolved fluorescence enhanced diffuse optical tomography. Med. Phys. 34 12 (2007) 4890-4900
127. Leblond F., et al. Early photons fluorescence tomography: spatial resolution improvements and noise stability considerations. J. Opt. Soc. Am. A 26 (2009) 1444-1457
128. Kepshire D., et al. Fluorescence tomography characterization for sub-surface imaging with protoporphyrin IX. Opt. Express 16 12 (2008) 8581-8593
129. Chang J.H., Graber H.L., and Barbour R.L. Imaging of fluorescence in highly scattering media. IEEE Trans. Biomed. Eng. 44 9 (1997) 810-822
130. Chang J., Graber H.L., and Barbour R.L. Luminescence optical tomography of dense scattering media. J. Opt. Soc. Am. A 14 1 (1997) 288-299
131. Herve L., et al. Noncontact fluorescence diffuse optical tomography of heterogeneous media. Appl. Opt. 46 22 (2007) 4896-4906
132. Hyde D., et al. A statistical approach to inverting the born ratio. IEEE Trans. Med. Imag. 26 7 (2007) 893-905
133. Joshi A., Bangerth W., and Sevick-Muraca E.M. Adaptative finite element based tomography for fluorescence optical imaging in tissue. Opt. Express 12 22 (2004) 5402-5417
134. Joshi A., Bangerth W., and Sevick-Muraca E.M. Non-contact fluorescence optical tomography with scanning patterned illumination. Opt. Express 14 14 (2006) 6516-6534
135. Joshi A., et al. Plane-wave fluorescence tomography with adaptative finite elements. Opt. Lett. 31 2 (2006) 193-195
136. Lasser T., and Ntziachristos V. Optimization of 360 degrees projection fluorescence molecular tomography. Med. Image Anal. 11 (2007) 389-399
137. Lee J., and Sevick-Muraca E.M. Three-dimensional fluorescence enhanced optical tomography using referenced frequency-domain photon migration measurements at emission and excitation wavelengths. J. Opt. Soc. Am. A, Opt., Image Sci., Vision 19 4 (2002) 759-771
138. L'Huillier J.-P., and Vaudelle F. Improved localization of hidden fluorescent objects in highly scattering slab media based on a two-way transmittance determination. Opt. Express 14 26 (2006) 12915-12929
139. Mohajerani P., et al. Optimal sparse solution for fluorescent diffuse optical tomography: theory and phantom experimental results. Appl. Opt. 46 10 (2007) 1679-1685
140. Mohajerani P., Eftekhar A.A., and Adibi A. Object localization in the presence of a strong heterogenous background in fluorescent tomography. J. Opt. Soc. Am. A 25 6 (2008) 1467-1479
141. Schulz R.B., et al. Comparison of noncontact and fiber-based fluorescence-mediated tomography. Opt. Lett. 31 6 (2006) 769-771
142. Schulz R.B., Ripoll J., and Ntziachristos V. Experimental fluorescence tomography of tissues with noncontact measurements. IEEE Trans. Med. Imag. 23 4 (2004) 492-500
143. Cong A.X., and Wang G. A finite-element-based reconstruction method for 3D fluorescence tomography. Opt. Express 13 24 (2005) 9847-9857
144. Song X., et al. Reconstruction for free-space fluorescence tomography using a novel hybrid adaptive finite element algorithm. Opt. Express 15 26 (2007) 18300-18317
145. Soubret A., and Ntziachristos V. Fluorescence molecular tomography in the presence of background fluorescence. Phys. Med. Biol. 51 (2006) 3983-4001
146. Wang D., Song X., and Bai J. Adaptative-mesh-based algorithm for fluorescence molecular tomography using an analytical solution. Opt. Express 15 15 (2007) 9722-9730
147. Wang D., Song X., and Bai J. Adaptative-mesh-based algorithm for fluorescence molecular tomography using an analytical solution: erratum. Opt. Express 15 17 (2007) 10789
148. Zou W., Wang J., and Feng D.D. Fluorescent molecular tomographic image reconstruction based on the Green's function. J. Opt. Soc. Am. A 24 7 (2007) 2014-2022
149. Graves E.E., et al. Singular-value analysis and optimization of experimental parameters in fluorescence molecular tomography. J. Opt. Soc. Am. A, Opt., Image Sci., Vision 21 2 (2004) 231-241
150. Graves E.E., et al. Validation of in vivo fluorochrome concentrations measured using fluorescence molecular tomography. J. Biomed. Opt. 10 4 (2005) 044019 1-044019 10
151. Eppstein M.J., et al. A comparison of exact and approximate adjoint sensitivities in fluorescence tomography. IEEE Trans. Med. Imag. 22 10 (2003) 1215-1223
152. Fedele F., Laible J.P., and Eppstein M.J. Coupled complex adjoint sensitivities for frequency-domain fluorescence tomography: theory and vectorized implementation. J. Comput. Phys. 187 (2003) 597-619
153. Klose A.D., and Hielscher A.H. Fluorescence tomography with simulated data based on the equation of radiative transfer. Opt. Lett. 28 12 (2003) 1019-1021
154. Schulz R.B., Ripoll J., and Ntziachristos V. Noncontact optical tomography of turbid media. Opt. Lett. 28 18 (2003) 1701-1703
155. Ntziachristos V., and Weissleder R. Experimental three-dimensional fluorescence reconstruction of diffuse media by use of a normalized born approximation. Opt. Lett. 26 12 (2001) 893-895
156. Chang J., Graber H.L., and Barbour R.L. Improved reconstruction algorithm for luminescence optical tomography when background lumiphore is present. Appl. Opt. 37 16 (1998) 3547-3552
157. Gao M., et al. Effects of background fluorescence in fluorescence molecular tomography. Appl. Opt. 44 26 (2005) 5468-5474
158. Chaudhari A.J., et al. Hyperspectral and multispectral bioluminescence optical tomography for small animal imaging. Phys. Med. Biol. 50 (2005) 5421-5441
159. Zacharopoulos A., et al. A matrix-free algorithm for multiple wavelength fluorescence tomography. Opt. Express 17 5 (2009) 3025-3035
160. Axelsson J., Svensson J., and Andersson-Engels S. Spatially varying regularization based on spectrally resolved fluorescence molecular tomography. Opt. Express 15 21 (2007) 13574-13584
161. Quan H., and Guo Z. Fast 3-D optical imaging with transient fluorescence signals. Optics Express 12 3 (2004) 449-457
162. Gao F., et al. A linear, featured-data scheme for image reconstruction in time-domain fluorescence molecular tomography. Opt. Express 14 16 (2006) 7109-7124
163. Gao F., et al. A self-normalized, full time-resolved method for fluorescence diffuse optical tomography. Opt. Express 16 17 (2008) 13104-13121
164. O'Leary M.A., et al. Fluorescence lifetime imaging in turbid media. Opt. Lett. 21 2 (1996) 158-160
165. Paithankar D.Y., et al. Imaging of fluorescent yield and lifetime from multiply scattered light reemitted from random media. Appl. Opt. 36 10 (1997) 2260-2272
166. Shives E., Xu Y., and Jiang H. Fluorescence lifetime tomography of turbid media based on an oxygen-sensitive dye. Opt. Express 10 26 (2002) 1557-1562
167. Chang J.W., Graber H.L., and Barbour R.L. Luminescence optical tomography of dense scattering media. J. Opt. Soc. Am. A, Opt. Image Sci. Vision 14 1 (1997) 288-299
168. Milstein A.B., et al. Fluorescence optical diffusion tomography using multiple-frequency data. J. Opt. Soc. Am. A, Opt, Image Sci, & Vision 21 6 (2004) 1035-1049
169. Roy R., and Sevick-Muraca E.M. Truncated Newton's optimization scheme for absorption and fluorescence optical tomography: part II reconstruction from synthetic measurements. Opt. Express 4 10 (1999) 372-382
170. Soloviev V.Y. Mesh adaptation technique for Fourier-domain fluorescence lifetime imaging. Med. Phys. 33 11 (2006) 4176-4183
171. Soloviev V.Y., et al. Fluorescence lifetime imaging by using time-gated data acquisition. Appl. Optics 46 30 (2007) 7384-7391
172. Godavarty A., Sevick-Muraca E.M., and Eppstein M.J. Three-dimensional fluorescence lifetime tomography. Med. Phys. 32 4 (2005) 992-1000
173. Lin Y., Gao H., and Gulsen G. Fluorescence diffuse optical tomography with functional and anatomical a priori information: feasibility study. Phys. Med. Biol. 52 (2007) 5569-5585
174. Lin Y., et al. Quantitative fluorescence tomography with functional and structural a priori information. Appl. Opt. 48 7 (2009) 1328-1336
175. Tan Y., and Jiang H. DOT guided fluorescence molecular tomography or arbitrarily shaped objects. Med. Phys. 35 12 (2008) 5703-5707
176. Tan Y., and Jiang H. Diffuse optical tomography guided quantitative fluorescence molecular tomography. Appl. Opt. 47 12 (2008) 2011-2016
177. Niedre M., and Ntziachristos V. Elucidating structure and function in vivo with hybrid fluorescence and magnetic resonance imaging. Proc. IEEE 96 3 (2008) 382-387
178. Tran Cao H.S., et al. Development of the transgenic cyan fluorescent protein (CFP)-expressing nude mouse for "Technicolor" cancer imaging. J. Cell. Biochem. 107 (2009) 328-334